{
    "root": "e06f7da2-08df-4336-82c1-fe637019c819",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Topiramate",
    "value": "20250428",
    "ingredients": [
        {
            "name": "TOPIRAMATE",
            "code": "0H73WJJ391",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_63631"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        }
    ],
    "indications": {
        "text": "topiramate tablets indicated : \u2022 epilepsy : initial monotherapy treatment partial-onset primary generalized tonic-clonic seizures patients 2 years age older ( 1.1 ) ; adjunctive therapy treatment partial-onset seizures , primary generalized tonic-clonic seizures , seizures associated lennox-gastaut syndrome patients 2 years age older ( 1.2 ) \u2022 preventive treatment migraine patients 12 years age older ( 1.3 )",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            },
            {
                "text": "lennox-gastaut syndrome (DOID:0050561)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050561"
            },
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            },
            {
                "text": "migraine (DOID:6364)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6364"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "lennox-gastaut syndrome",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_2382"
            }
        ]
    },
    "contraindications": {
        "text": "topiramate tablets initial dose , titration , recommended maintenance dose varies indication age group . full prescribing information recommended , dosing considerations patients renal impairment , geriatric patients , patients undergoing hemodialysis ( 2.1 , 2.2 , 2.3 , 2.4 , 2.5 , 2.6 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "topiramate tablets , usp available circular , biconvex , film-coated tablets following strengths colors : 25 mg white tablets \u2018 g \u2019 engraved one side \u2018 25 \u2019 side . bottles 60 count desiccant ( ndc 68462-108-60 ) bottles 500 count desiccant ( ndc 68462-108-05 ) bottles 1,000 count desiccant ( ndc 68462-108-10 ) 50 mg yellow tablets \u2018 g \u2019 engraved one side \u2018 50 \u2019 side . bottles 60 count desiccant ( ndc 68462-153-60 ) bottles 500 count desiccant ( ndc 68462-153-05 ) bottles 1,000 count desiccant ( ndc 68462-153-10 ) 100 mg yellow tablets \u2018 g \u2019 engraved one side \u2018 100 \u2019 side . bottles 60 count desiccant ( ndc 68462-109-60 ) bottles 500 count desiccant ( ndc 68462-109-05 ) bottles 1,000 count desiccant ( ndc 68462-109-10 ) 200 mg pink tablets \u2018 g \u2019 engraved one side \u2018 200 \u2019 side . bottles 60 count desiccant ( ndc 68462-110-60 ) bottles 500 count desiccant ( ndc 68462-110-05 ) bottles 1,000 count desiccant ( ndc 68462-110-10 )",
    "adverseReactions": "none .",
    "indications_original": "Topiramate tablets are indicated for: \u2022 Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older ( 1.1 ); adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older ( 1.2 ) \u2022 Preventive treatment of migraine in patients 12 years of age and older ( 1.3 )",
    "contraindications_original": "Topiramate tablets initial dose, titration, and recommended maintenance dose varies by indication and age group. See Full Prescribing Information for recommended dosage, and dosing considerations in patients with renal impairment, geriatric patients, and patients undergoing hemodialysis ( 2.1 , 2.2 , 2.3 , 2.4 , 2.5 , 2.6 )",
    "warningsAndPrecautions_original": "Topiramate Tablets, USP are available as circular, biconvex, film-coated tablets in the following strengths and colors:\n                        25 mg white tablets with \u2018G\u2019 engraved on one side and \u201825\u2019 on the other side.\n                        \n                           \n                              \u00a0Bottles of 60 count with desiccant (NDC 68462-108-60)\n                           \n                              \u00a0Bottles of 500 count with desiccant (NDC 68462-108-05)\n                           \n                              \u00a0Bottles of 1,000 count with desiccant (NDC 68462-108-10)\n                        \n                        50 mg yellow tablets with \u2018G\u2019 engraved on one side and \u201850\u2019 on the other side. \n                        \n                           \n                              \u00a0Bottles of 60 count with desiccant (NDC 68462-153-60)\n                           \n                              \u00a0Bottles of 500 count with desiccant (NDC 68462-153-05)\n                           \n                              \u00a0Bottles of 1,000 count with desiccant (NDC 68462-153-10)\n                        \n                        100 mg yellow tablets with \u2018G\u2019 engraved on one side and \u2018100\u2019 on the other side. \n                        \n                           \n                              \u00a0Bottles of 60 count with desiccant (NDC 68462-109-60)\n                           \n                              \u00a0Bottles of 500 count with desiccant (NDC 68462-109-05)\n                           \n                              \u00a0Bottles of 1,000 count with desiccant (NDC 68462-109-10)\n                        \n                        200 mg pink tablets with \u2018G\u2019 engraved on one side and \u2018200\u2019 on the other side. \n                        \n                           \n                              \u00a0Bottles of 60 count with desiccant (NDC 68462-110-60)\n                           \n                              \u00a0Bottles of 500 count with desiccant (NDC 68462-110-05)\n                           \n                              \u00a0Bottles of 1,000 count with desiccant (NDC 68462-110-10)",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Topiramate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_63631"
        }
    ]
}